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Abstract 
Glycosaminoglycans (GAGs) and GAG-
degrading enzymes have wide-ranging 
applications in the medical and biotechnological 
industries. The former are also an important 
nutrient source for select species of the human 
gut microbiota (HGM), a key player in host-
microbial interactions. How GAGs are 
metabolized by the HGM is therefore of interest 
and has been extensively investigated in the 
model human gut microbe Bacteroides 
thetaiotaomicron. The presence of yet 
uncharacterized GAG-inducible genes in its 
genome and that of related species however, is 
testament to our incomplete understanding of 
this process. Nevertheless, it presents a potential 
opportunity for the discovery of additional 
GAG-degrading enzymes. Here, we investigated 
a gene of unknown function (BT_3328) from the 
chondroitin sulfate (CS) utilization locus of B. 
thetaiotaomicron. NMR and UV spectroscopic 
assays revealed that it encodes a novel 
polysaccharide lyase (PL), hereafter referred to 
as BtCDH, reflecting its source (B. 
thetaiotaomicron or Bt) and ability to degrade 
the GAGs CS, dermatan sulfate (DS) and 
hyaluronic acid (HA). When incubated with HA, 
BtCDH generated a series of unsaturated HA 
sugars including Δ4,5UA-GlcNAc, Δ4,5UA-
GlcNAc-GlcA-GlcNac, Δ4,5UA-[GlcNAc-
GlcA]2-GlcNac and Δ
4,5
UA-[GlcNAc-GlcA]3-
GlcNac) as end products and hence was classed 
as endo-acting. A combination of genetic and 
biochemical assays revealed that BtCDH 
localizes to the cell surface of B. 
thetaiotaomicron where it enables extracellular 
GAG degradation. BtCDH homologues were 
also detected in several other HGM species and 
we therefore propose that it represents the 
founding member of a new polysaccharide lyase 
family (PL29). The current discovery also 
contributes new insights into CS metabolism by 
the HGM. 
Introduction 
Mammalian glycosaminoglycans (GAGs) are 
complex carbohydrates consisting of repeating 
disaccharide units of uronic acids or galactose 
linked to a hexosamine sugar (1, 2).  These 
include chondroitin sulfate (CS) made up of 
glucuronic acid (GlcA) and N-
 http://www.jbc.org/cgi/doi/10.1074/jbc.RA118.004510The latest version is at 
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acetylgalactosamine (GalNAc), dermatan sulfate 
(DS) or chondroitin sulfate B (CSB) made up of 
iduronic (IdoA) acid and GalNAc, hyaluronic 
acid (HA) made up of GlcA and N-
acetylglucosamine (GlcNAc), heparin/heparan 
sulfate (HS) made up of a mixture of GlcA and 
IdoA linked to GlcNAc and keratan sulfate (KS) 
made up of galactose (Gal) linked to GlcNAc. 
GAGs such as CS, DS and HS are also 
characterised by highly diverse sulfation patterns 
(introduced during biosynthesis by specific 
sulfotransferase enzymes) which define various 
molecular subtypes of each glycan (3, 4). CS for 
example can be sulfated on GalNAc at different 
positions including C4, C6 or both to yield major 
CS subtypes namely CSA, CSC and CSE 
respectively (5, 6) or at both C2 of GlcA and C6 
of GalNAc yielding CSD (7). In contrast, HA is 
not sulfated and hence less structurally complex 
compared to the other GAG types.  
GAGs are ubiquitously distributed in the human 
body and implicated in several important 
physiological processes such as cell signalling, 
inflammation, neuronal development, adhesion 
and tumour progression (8-11). Dietary GAGs 
are also a nutrient source for the human gut 
microbiota (HGM) which is known to impact 
greatly on human health and disease status (12-
17). Indeed recent evidence suggests that CS is a 
priority nutrient for prominent gut microbes such 
as B. thetaiotaomicron and B. ovatus and that 
only a subset of HGM species are capable of 
metabolising the GAG (13, 15, 17). 
Understanding how GAGs are metabolised could 
therefore inform strategies including nutrient-
based approaches to manipulate the HGM and 
hence improve human health.  In line with this, 
several studies (reviewed in Ndeh et al., 2018 
(18)) have examined the metabolism of dietary 
GAGs by the HGM. The results demonstrate that 
GAG degradation is largely orchestrated by a 
combination of three major enzyme types 
including polysaccharide lyases (PLs, EC 4.2.2.-
), sulfatases (EC 3.1.6.-) and glycoside 
hydrolases (EC 3.2.1.- ). In the model human gut 
microbe B. thetaiotaomicron as well as other gut 
Bacteroidetes, the genes encoding these enzymes 
are typically located within polysaccharide 
utilization loci (PULs)(14, 19-21). These genetic 
loci are diverse and encode a variety of cell-
envelop associated multiprotein systems 
involved in complex glycan metabolism. 
Although the mechanisms of various GAG PULs 
in these organisms have been extensively 
investigated, knowledge of their functioning is 
incomplete, evident by the presence of yet 
uncharacterised GAG-inducible genes within  
these PULs (21). In the CS PUL of B. 
thetaiotaomicron, three of such genes BT_3328, 
BT_3329 and BT_3330 (all of unknown 
function) appear in a distinct operon (BT_3328-
30) conserved in several HGM Bacteroidetes 
(14, 20, 21). The latter suggests that they might 
be an important adaptation for CS metabolism in 
these microbes.  Here, we characterised the 
largest member of this operon (BT_3328), 
revealing that it encodes a novel polysaccharide 
lyase hereafter referred to as BtCDH, reflecting 
its source (B. thetaiotaomicron or Bt) and ability 
to degrade the GAGs CS, DS and HA.  We also 
provide evidence suggesting that BtCDH is not 
only the founding member of a novel enzyme 
family but also a cell surface GAG degrading 
enzyme, the first to be reported in B. 
thetaiotaomicron and related species. Taken 
together, our findings contribute new insights 
into our knowledge of CS metabolism by the 
HGM, a key player in host-microbial 
interactions. 
Results 
In silico data on native BtCDH lyase 
The gene encoding native BtCDH lyase 
(BT_3328 from B. thetaiotaomicron VPI-5482) 
is 2607 bp in length and has a GC content of 
51%. BtCDH is a large protein of 868 amino 
acid residues, a molecular mass of 96 kDa and 
an isoelectric pI of 5.33. A majority of the top 
hits (>50% identity) from a BLASTp search with 
native BtCDH are hypothetical/putative 
uncharacterised proteins mainly annotated as 
DUF4955 domain-containing. The DUF4955 
domain whose function is unknown is present at 
the C-terminal of the protein while another 
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domain DUF4988 is located directly after the 
putative lipoprotein signal peptide sequence at 
the N-terminus of the protein (Fig. 1A).   Top 
BtCDH lyase homologues were mostly detected 
in species from the Bacteroides, Alistipes and 
Prevotella genera, all highly represented in the 
HGM. They were also prominent in species from 
marine environments including Saccharophagus 
degradans, Zobellia galactinovorans andVibrio 
harveyi or Coraliomargarita akajimensis. A 
phylogenetic tree of selected homologs of 
BtCDH is presented in Fig. 1B. 
Activity of BtCDH 
Purified recombinant BtCDH was initially 
assayed spectrophotometrically using CS from 
bovine trachea (which is mainly CS-4 sulfate or 
CSA (22)) (Fig. 2A) as substrate. BtCDH 
degraded CSA generating unsaturated products 
which were detected by thin layer 
chromatography (TLC) and high performance 
anion exchange chromatography (HPAEC) using 
a UV detector at 235 nm (A235) (Fig. 2B and 2C 
respectively). Limit products of the reaction 
were also resolved by size exclusion 
chromatography (SEC) and analysed by 
1
H 
NMR (Fig. 2D, Supplemental Fig.1). Distinct 
resonance signals were detected at 5.9 and 5.2 
ppm in the spectra of the digested products as 
opposed to undigested CSA. The former is 
evidence of a H4 proton chemical shift 
consistent with glyosidic bond cleavage and the 
generation of C4,5 double bonds (Δ4,5) in the 
terminal non-reducing end GlcA or uronic acid 
(UA) residue (Δ4,5UA) of various products, while 
the latter peak at 5.2 ppm corresponds to 
resonance signals of the H1 anomeric proton of 
the same sugar (Fig. 2D), (23-26). 
To explore the substrate specificity in BtCDH in 
more detail, the enzyme was also tested against a 
series of commercially available uronic acid-
based substrates including CS from shark 
cartilage (mainly CS-6 sulfate or CSC), DS from 
porcine intestinal mucosa (mainly DS-4 sulfate), 
high and low molecular weight HA sodium salt 
from Streptococcus equi (10,000-30,000 (HAL) 
and 90,000-110,000 Da (HAH) respectively), 
heparin, alginate, ulvan and polygalacturonic 
acid. BtCDH was active against CS DS and HA 
(in the order CSC>CSA/HAL>DS>HAH) but not 
heparin, alginate, ulvan and polygalacturonic 
acid (Table 1). Previous studies analysing CSA 
and CSC have reported major differences in the 
sulfated disaccharide composition of both 
substrates with the most prominent being the 
levels of the ∆UA-GalNAc4S which is higher in 
CSA and ∆UA-GalNAc6S which is higher in 
CSC (12, 22, 27, 28). BtCDH activity thus 
appears to be affected by the type of sulfation in 
the GAG substrates. 
Degradation pattern and mode of BtCDH 
lyase activity 
To determine whether BtCDH was endo or exo-
acting, we performed time course experiments 
with HAL, a less chemically complex GAG 
compared to its sulfated counterparts. HAL was 
incubated with BtCDH over different times (0, 1, 
5, 60 min and ~12 h (ON) after which reactions 
were stopped by boiling and analysed by TLC. 
BtCDH degraded HAL within 10 min generating 
a fast migrating band (Band A), (Fig. 3A). After 
1 h of the reaction, the original HAL spot at the 
origin disappeared accompanied by the 
appearance another major band (Band B) as well 
as low staining intermittent bands (Fig. 3A).  
The pattern of products remained unchanged 
even after overnight digestion and hence the 
generated sugars represented the final limit 
products of HAL digestion. Bands A and B limit 
products were purified by SEC and analysed by 
mass spectrometry (HILIC LC-MS). Purified 
Band A yielded incremental masses of 380.117, 
381.120 and 382.123 Da (differing by a mass of 
1 Da) equivalent to the mass of singly charged 
ions of the unsaturated Δ4,5UA-GlcNAc 
disaccharide, while band B yielded incremental 
masses of 759.227, 759.729 and 760.230 Da 
(differing by a mass of 1/2 Da)  etc (Fig. 3B) 
equivalent to the mass of doubly charged 
fragments derived from the unsaturated Δ4,5UA-
[GlcNAc-GlcA]3-GlcNAc octasaccharide parent 
ion. To detect underrepresented sugars, all SEC 
fractions were pooled in one sample and 
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analysed. The spectra revealed the presence of 
new products with incremental masses of 
759.226, 760.230 and 761.232 (differing by a 
mass of 1 Da) and 1138.337, 1139.340 and 
1140.344 (differing by a mass of 1 Da) 
corresponding to singly charged ions of the 
unsaturated Δ4,5UA-GlcNAc-GlcA-GlcNAc 
tetrasaccharide and Δ4,5UA-[GlcNAc-GlcA]2-
GlcNAc hexasaccharide sugars respectively 
(Fig. 3B). The generation of diverse molecular 
weight limit products thus suggests that BtCDH 
is an endo-acting enzyme. In addition, the 
accumulation of the high molecular weight HA 
octasaccharide suggests that BtCDH 
preferentially cleaves sugars with a degree of 
polymerisation (DP) typically greater than or 
equal to 10 (≥DP10). The requirement for 
substrates with a DP≥10 was also demonstrated 
using sulfated CS oligosaccharides as substrates 
with HPAEC data showing a major shift in the 
DP10 oligosaccharide profile (as opposed to a 
minor shift for DP8) after treatment with BtCDH 
(Fig. 4). The proportion of each HA product 
generated was also determined by UV with the 
results showing that over 70% of the generated 
products were Δ4,5UA-GlcNAc disaccharides 
(Supplemental Fig. 2).  Time course experiments 
with sulfated GAGs CSA and CSC as substrates 
also yielded fairly similar patterns observed for 
HAL (Supplemental Fig. 3). As with HAL, high 
amounts of the basic disaccharide building block 
(Δ4,5UA-GalNAc) were detected suggesting high 
processivity in the enzyme.   
Impact of Temperature, pH and metals on 
BtCDH 
The effects of temperature, pH and metal ions on 
BtCDH activity were tested with CSA as 
substrate. BtCDH preferred higher reaction 
temperatures with the activity increasing linearly 
from 20 
o
C to a maximum rate of about 15 
µM/min at 60 
o
C (Fig. 5A). After this optimum 
temperature, the enzyme activity dropped 
sharply. To determine the optimum pH of 
BtCDH, enzyme activity was examined against 
CSA in different buffers over a pH range of 4 to 
9. BtCDH activity rose gradually with increase 
pH between 4 and 6 and then sharply to an 
optimum pH of 7.0 in 10 mM MES buffer (Fig. 
5B).  BtCDH activity against CS was also tested 
in the presence of 5 mM EDTA and metal ions 
including Mg
2+
, Ca
2+
, Mn
2+
, Co
2+
 and Zn
2+
 and 
Ni
2+
. Its activity was only slightly affected by 
metals with the most inhibition (27.42%) 
observed in the presence of Co
2+
ions (Fig. 5C). 
Growth experiments  
A genetic mutant ΔBtCDH lacking the entire 
ORF for BtCDH (the BT_3328 gene) was 
created by counter selectable allelic exchange. 
Growth experiments with both B. 
thetaiotaomicron wild type (WT) and ΔBtCDH 
strains were carried out with four different GAG 
substrates CSA, DS, CSC, HAL and glucose as 
sole carbon source for at least 24 h. B. 
thetaiotaomicron WT and ΔBtCDH cells grew at 
a very similar rates on various substrates except 
for CSC where a minor defect in late phase 
growth was observed (Supplemental Fig. 4). 
Polyclonal antibodies and cellular localization 
assays 
Polyclonal antibodies to BtCDH detect two 
forms of the protein: Rabbit anti-BtCDH 
polyclonal antibodies where generated using the 
recombinant BtCDH protein as immunogen. On 
western blots containing cell free extracts of B. 
thetaiotaomicron grown on CSA, two 
immunosensitive bands (BtCDHH and BtCDHL 
of high and low molecular weights respectively) 
were detected (Fig. 6A). Despite its poor 
enrichment relative to BtCDHL, BtCDHH’s 
molecular weight was close to 96 kDa 
corresponding to the mass of native BtCDH 
while the mass of BtCDHL was about 30 kDa.  
Interestingly, when cell extracts of the ΔBtCDH 
strain lacking BtCDH were tested with the same 
antibodies, both bands were not detected, 
suggesting that BtCDHL is a subcomponent 
possibly a truncated form of BtCDH (Fig. 6A 
top). To confirm this, BtCDH was FLAG-tagged 
(BtCDHFLAG) by genetically introducing a 
FLAG peptide sequence (DYKDDDK) at the C-
terminal of the protein, thus allowing for its 
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detection using rabbit anti-FLAG specific 
antibodies. Under these circumstances, only 
BtCDHH was detected by immunoblotting (Fig. 
6A) suggesting that BtCDHL was an N-terminal 
truncated version of BtCDH.  
Proteinase K, immunofluorescence and whole 
cell assays: As earlier indicated BtCDH contains 
an N-terminal lipidation sequence (Fig. 1A) and 
hence is potentially localized extracellularly at 
the cell surface of B. thetaiotaomicron. To 
confirm this experimentally, we performed 
proteinase K (PK) and immunofluorescence 
assays. B. thetaiotaomicron WT cells were 
grown to exponential phase in 1% CSA, 
harvested and treated with 0.5 mg/ml PK. 
Treated and untreated cells (controls) were lysed 
under reducing conditions and cell extracts 
analysed by western blotting using anti-BtCDH 
antibodies. The results showed degradation of 
BtCDHL and BtCDHH in PK treated but not 
control cells (Fig. 6B). The experiment was also 
controlled by immunoblotting the same extracts 
with polyclonal antibodies targeting the 
constitutively expressed periplasmic heparin 
lyase BT4657 (16) whose bands remained intact 
in test and control extracts (Fig. 6B). The data 
thus suggests that BtCDH is localized to cell 
surface of B. thetaiotaomicron. The cell surface 
localization of BtCDH was finally confirmed 
through immunofluorescence assays using anti-
BtCDH antibodies (Fig. 6C). We also performed 
whole cell aerobic assays on B. thetaiotaomicron 
WT and ΔBtCDH following growth on CSA. 
Under these conditions, transport across the 
outer membrane is limited and only surface 
enzyme activity is detected. Cells were harvested 
at exponential phase and re-incubated with CSA 
and CSC for 2 h and the reaction examined by 
TLC. The results showed extensive degradation 
of both CSA and CSC by the wild-type strain, 
visible as a smear of products (Fig. 6D).  This 
was significantly reduced in the knockout strain 
especially for the CSA substrate where just a 
single band of generated product was observed 
(Fig. 6D). Supernatants at exponential phase 
were also analysed for secreted BtCDH by 
western blotting with polyclonal rabbit anti-
BtCDH antibodies but only a faint band of the 
truncated form BtCDHL was detected 
(Supplemental Fig 5). Finally culture 
supernatants from B. thetaiotaomicron WT and 
ΔBtCDH at exponential phase were tested for 
secreted activity but the TLC profiles of the 
treated and untreated CS substrates were very 
similar, except for a major band initially present 
in the supernatants (Supplemental Fig. 5B, C, 
D). We thus conclude that BtCDH activity is 
mainly present at the cell surface of B. 
thetaiotaomicron.  
Discussion 
In this study, we discovered and characterised 
the founding member of a novel family of GAG 
lyases from the prominent gut bacterium B. 
thetaiotaomicron. BtCDH is encoded by a gene 
from an operon (BT3328-30) of unknown 
function within the CS PUL of B. 
thetaiotaomicron (14) and hence until now, its 
function was unknown. We show that BtCDH 
exhibits polysaccharide lyase activity towards a 
variety of GAGs substrates including CS, DS, 
and HA. BtCDH alongside previously 
characterised CS ABC lyases from B. 
thetaiotaomicron WAL2926 (BactnABC) (22)  
and Proteus vulgaris (ChS ABC lyase I and ChS 
ABC lyase II) (29), named after their ability to 
degrade CSA, DS or CSB and CSC  are the only 
few lyases known to exhibit such broad GAG 
substrate specificity. BtCDH however displays 
very low catalytic efficiency (based on kcat/Km 
values) when compared to both enzymes. B. 
stercoris, Pedobacter saltans, Flavobacterium 
heparinum, Vibrio sp. FC509 CS AC lyases 
degrade a variety of GAGs but are unable to 
degrade DS (2, 23, 30, 31) while B. stercoris 
ABC and F. heparinum ABC lyases which are 
capable of degrading DS and CS are unable to 
degrade HA(2).  We also show, using HA as 
substrate that BtCDH exhibits an endo-mode of 
activity, preferentially targeting oligosaccharides 
with DP≥10.  It may be possible that BtCDH 
contains over 10 subsites in its active site, 
however, further 3D structural studies of the 
enzyme in complex with the substrate (for which 
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attempts were made in this study but were 
unsuccessful) will be required to determine this.   
The enzyme also showed optimum activity at a 
very high temperature ~ 60 
o
C, contrary to most 
PLs with optimum temperatures between 30 - 40
 
o
C (2, 22, 23, 29, 31). A notable exception is the 
ScPL8H lyase from Streptomyces coelicolor A3 
(a non-pathogenic filamentous soil bacterium) 
with an optimum temperature of 57 
o
C (32). 
BtCDH activity was also only slightly affected 
by EDTA and the divalent metal ions tested in 
this study. Although it is possible that a metal 
ion inaccessible to EDTA chelation maybe 
present and directly or indirectly involved in 
enzyme activity,  the low sensitivity to diverse  
metals, broad CS substrate specificity and 
thermophilic nature of BtCDH make it an 
attractive target from a biotechnological 
perspective. It is also worth noting that of the 28 
PL families known to date, only 3 contain CS 
lyases (33) and hence BtCDH and family 
members make an important addition to this 
group of enzymes in terms of the diversity of 
enzymatic options available for CS related 
investigations. The current family has now been 
designated polysaccharide lyase family 29 
(PL29). Its presence in species from diverse 
environments including soil and marine bacteria 
also suggests that it may serve as an important 
adaptation for CS metabolism in these 
environments  
Another major finding in our study was the 
extracellular localization of BtCDH in B. 
thetaiotaomicron. The significance of this 
discovery lies in the fact that until now, models 
of CS metabolism did not include extracellular 
cell surface degradation of the substrate as no 
such enzymes had been reported in this organism 
before. In a recent report by Raghavan et al., 
2014 and Raghavan and Groisman, 2015 (14, 
20), extracellular CS is bound and directly 
transported by a SusCD-like complex (BT3331-
3332) into the periplasmic space without any 
initial extracellular cleavage. Hence to date, 
general consensus has held that enzymatic CS 
degradation begins in the periplasmic space of B. 
thetaiotaomicron.   We not only present 
evidence of the extracellular localization of 
BtCDH but show through whole cell assays that 
B. thetaiotaomicron is capable, with the aid of 
BtCDH of degrading CS extracellularly. 
Although our growth data did not show a 
significant defect in B. thetaiotaomicron’s ability 
to utilise most of the GAG substrates during 
growth, extracellular substrate degradation in a 
complex polymicrobial setting like the HGM 
could have significant implications for 
competition or cooperation between HGM 
species and hence microbial community 
structure. We also observed that the absence of 
BtCDH did not completely prevent extracellular 
degradation of CS in whole cell assays, 
suggesting the presence of other unknown 
surface CS degrading enzymes. This was more 
pronounce in whole cell assays involving CSC 
where the mutant strain still showed significant 
CS degradation compared to the wild type. 
Nevertheless, based on the evidence thus far for 
BtCDH, we propose a modification of the 
current model for CS metabolism in B. 
thetaiotaomicron to include the extracellular CS 
degrading activity encoded by BtCDH (Fig. 7). 
In this model, a complexly sulfated CS substrate 
such as CSC with a high degree of 
polymerisation (dp≥10) is initially cleaved on 
the cell surface generating oligosaccharides 
which are then bound and transported into the 
periplasmic space for further degradation by 
periplasmic enzymes as previously described 
(12, 14, 34) (also see Fig. 7). In future studies, 
we will also investigate the possibility that 
extracellular CS oligosaccharides generated by 
BtCDH e.g. in the case of CSA are the basis of 
cross-feeding and inter-bacterial interactions 
which may influence host health.   
To conclude, our current findings not only 
satisfy the growing demand for novel 
biocatalysts for modern biotechnological and 
medical research applications but contribute new 
insights relevant to our understanding of CS or 
complex glycan metabolism by the HGM, a key 
player in host-microbial interactions. 
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Materials and methods 
Plasmid Construction and heterologous 
protein expression 
The full length BtCDH gene lacking the N-
terminal lipoprotein signal sequence was 
amplified by PCR from Bacteroides 
thetaiotaomicron VPI-5482 genomic DNA using 
primers (BtCDHF: 
CGCGGGATCCgacgaacgggatgatctg, 
BtCDHR:CGCGCTCGAGttatttaagtgcgttgagccat
c) containing BamHI and XhoI restriction sites 
respectively. The gene was cloned into pET-28a 
(+) vector (Novagen) which introduces a C-
terminal 6xHis-tag. For this, E.coli TOP10 cells 
(ThermoFisher Scientific) were used. The 
recombinant construct was sequenced (Eurofins 
Genomics) and later used to transform E.coli 
BL21 (DE3) expression cells (ThermoFisher 
Scientific). Cells were cultured in Luria-Bertani 
(LB) medium containing with 10 µg/ml 
kanamycin antibiotic to mid-log phase (A600 of 
0.6). Protein expression was induced by adding 
0.01 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) to cells followed by growth overnight at 
16 
o
C. The next day, cells were harvested by 
centrifugation (4000 x g) and re-suspended in 
Talon buffer (20 mM Tris/HCl pH 8.0 plus 100 
mM NaCl). Cells were then disrupted and 
centrifuged (16 000 x g) for 20 min at 4 °C. 
BtCDH was then purified from the resulting cell 
free extract by immobilised metal affinity 
chromatography using fresh Talon resins 
(Clontech Laboratories Inc.). In the process, the 
CFE was loaded in a column containing the 
Talon resin and later washed with Talon buffer. 
Another wash was performed with Talon buffer 
containing 10 mM imidazole followed by 
recombinant protein elution with 100 mM 
imidazole. Purified proteins were analysed by 
SDS-PAGE (12.5% gels) under reducing 
conditions. The analyses revealed a major 
protein band of about 96 kDa, consistent with 
the predicted size of BtCDH. Samples were 
pooled and buffer exchanged into 20 mM 
NaH2PO4 buffer, pH 7.0 or other buffers of 
choice depending on the intended use 
Enzyme assays and biochemical properties of  
BtCDH 
Activity assays against various GAGs were 
performed at 37 
o
C in 20 mM sodium phosphate 
buffer, pH 7.0. The final reaction volume was 
600 µl containing 10 nM of enzyme in all cases 
except HA (containing 40 nM of enzyme) and 
varying concentrations of the substrate. 
Reactions were monitored using a Ultrospec 
4000, UV/Visible spectrophotometer at A235. To 
determine the optimum temperature of BtCDH 
activity, 40 µM of CSA was digested with 10 
nM of BtCDH at different temperatures and the 
activity monitored. To determine the optimum 
pH, the same reaction was performed at different 
pHs with 20 mM of each buffer. For metal 
dependency assays, various metals (5 mM for 
Mg
2+
, Ca
2+
, Mn
2+
, Co
2+
 and 1 mM for Zn
2+
 and 
Ni
2+
) as well as EDTA (5 mM) were included in 
separate reactions and their effects on enzyme 
activity tested.  
Thin layer chromatography (TLC) 
Enzymatic reactions were stopped by heating at 
98 
o
C for 3 mins and later centrifuged at 16 000 
x g for 1 min. Each reaction (2 µl drops) was 
spotted onto a Silicagel 60 TLC plate (Merck) 
and components resolved in a mobile phase 
containing butanol/acetic acid/water (2:1:1, v/v). 
Plates were later dried and developed with 
orcinol-sulfuric acid reagent (containing 0.1% 
orcinol and sulfuric acid, ethanol, water in the 
ratio 3.2:75:21.5 v/v). To visualise sugar bands, 
plates were gently warmed near a bunsen flame 
Size exclusion chromatography (SEC) of 
polysaccharides 
Samples (5 ml) were resolved using a Bio-Gel® 
P2 size-exclusion gels packed in Econo-
Column® chromatography columns (Biorad). 
The mobile phase was 50 mM acetic acid and 
the pump flow rate was set at 0.2 ml min−1. For 
small scale (200 µl) purifications, elution was 
achieved by gravity.  Fractions were later 
analysed by TLC.  
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NMR 
Digested products of CSA from bovine trachea 
were separated by SEC on a Bio-Gel® P2 size-
exclusion system (Biorad) and fractions analysed 
by TLC as described above. Purified fractions 
were collected and freeze dried at −50 °C using a 
CHRIST Gefriertrocknung ALPHA 1-2 
(Helmholtz-Zentrum) freeze-dryer. Samples 
were re-dissolved in 0.7 ml deuterium oxide 
(99.9 atom % D) for NMR analyses.  NMR 
spectra were obtained on a Bruker Avance III 
HD 700 MHz NMR spectrometer equipped with 
a TCI cryoprobe.  Spectra were acquired at 298K 
and were referenced to Trimethylsilyl propionate 
(TSP)  
High performance anion exchange 
chromatography (HPAEC)  
HPAEC analyses were carried out using an 
automated Dionex ICS3000 system (Dionex) 
fitted with Spherisorb
®
-SAX Columns and 
linked to an AD25 Absorbance Detector 
(Dionex). For HA samples, Dionex™ 
CarboPac™ PA1 columns (Dionex) were used. 
The mobile phase consisted of 3 M NaCl applied 
as a 0-100% gradient over 110 min. Data was 
analysed using the Chromeleon TM 
chromatography software (Version 6.8) 
(Dionex). 
BtCDH deletion mutant and FLAG-tagging 
 
ΔBtCDH and  BtCDHFLAG strains were 
generated through counter-selectable allelic 
exchange using the pExchange vector as   
described in Koropatkin et al., 2008 (35)  
 
Growth of B. thetaiotaomicron WT and 
mutant strains  
B. thetaiotaomicron WT, ΔBtCDH and 
BtCDHFLAG strains were cultured in 5 ml TYG 
(tryptone-yeast extract-glucose) medium at 37 
°C in an anaerobic cabinet (Whitley A35 
Workstation; Don Whitley). The next day 10 µl 
cells were added to 200 µl of minimal medium 
(Larsbrink et al., 2014) containing 1% of various 
GAGs plus 1.2 mg/ml porcine haematin (Sigma-
Aldrich). Cell growth was monitored at A600 
using a Gen5 v2.0 Microplate Reader (Biotek).  
 
Proteinase K experiments 
Experiments were performed as described in 
Ndeh et al., 2017 (36) with the following 
modifications; 1) B. thetaiotaomicron WT cells 
were grown in 5 ml minimal medium containing 
1% CSA from bovine trachea to exponential 
phase (OD600 of 0.8). Final cell pellets were 
dissolved in 300 μl Laemmli buffer and samples 
heated for 3 min. For each sample, 10 µl was 
analysed by SDS–PAGE (7.5%). 
Immunoblotting was performed with rabbit anti-
BtCDH antibodies at a 1:5000 dilution. For 
BtCDHFLAG cells, a 1:2000 dilution of rabbit 
anti-FLAG antibodies was used. In all cases, 
secondary antibodies were Goat Anti-Rabbit IgG 
Antibody, (H+L) HRP conjugate (Invitrogen) at 
a 1:4000 dilution. Signals were developed using 
Clarity™ Western ECL Substrate (Biorad). To 
detect the native control protein (BT4657), blots 
were washed overnight in PBS-tween 20 (1x 
PBS containing 5% tween 20) and re-probed 
with rabbit anti-BT4657 antibodies (1: 2000) as 
primary. 
 
Immunofluorescence assays 
B. thetaiotaomicron WT, ΔBtCDH and 
BtCDHFLAG cells were grown to exponential 
phase (A600 of 0.8) in 5 ml minimal medium 
containing 1% CSA from bovine trachea. Cells 
were fixed by adding an equal volume of cell 
culture to a 1 x PBS solution containing 3.7% 
formalin and rocking overnight at 4 
o
C. Cells 
were harvested by centrifugation at 4000 x g for 
5 min and washed in 5 ml PBS three times. Cells 
(1 ml) was later incubated in blocking solution 
(2% goat serum, 0.02% NaN3 in 1x PBS) 
overnight at 4
o
C while rocking. The next day 
cells were harvested by centrifugation at 16 000 
x g for 1 min and incubated with primary rabbit 
anti-BtCDH antibodies (1:1000) for 2 h at room 
temperature. Another PBS wash was performed 
and secondary Goat anti-Rabbit IgG (H+L) 
Cross-Adsorbed, Alexa Fluor 488 antibodies 
(ThermoFisher Scientific (cat. R37116)) added 
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according to the suppliers instructions. Cells 
were rocked for 30 min at room temperature and 
later washed two times in 1x PBS. The final 
pellet was re-suspended in 100 µl of PBS 
alongside 20 µM Hoechst 33342 nuclear stain 
(ThermoFisher Scientific (cat 62249). Samples 
were mounted on agarose beds (1% w/v in PBS) 
in Gene Frames (ThermoFisher Scientific (cat. 
AB0576) and visualised on a Zeiss Axio 
Observer Z1, with LSM800 confocal scan head. 
Images were taken using a 63x (N.A. 1.4) oil 
immersion lens with 5x scan zoom applied. 
Excitation of the Alexa 488 was performed using 
the 488 nm laser line, and the reflected light 
collected on a GaAsp detector between 510-700 
nm through the variable beam splitter dichroic 
block. Excitation of the Hoechst was performed 
using the 405 nm laser line with emission 
detected between 400-510 nm. A z-section of 25 
images was recorded with an interval of 0.1µm 
using Zeiss Zen 2.3 software with identical 
settings for all images. Deconvolution was 
carried out using Huygens Professional 
(Scientific Volume Imaging, NL) before a 
maximum intensity projection was carried out 
within ImageJ. 
Whole cell assays and supernatant analyses 
B. thetaiotaomicron WT, ΔBtCDH and 
BtCDHFLAG cells were cultured to exponential 
phase (A600 of 0.8) in 5 ml minimal medium. 
Cells (1 ml) were harvested at 4000 x g for 5 
min and washed once in 1 x PBS by centrifuging 
again at 4000 x g for 5 min. Cells were then re-
suspended in 100 µl of PBS containing 4% of 
the GAG substrate. Samples were incubated 
overnight for 2 h followed by centrifugation 
4000 x g for 5 min. The supernatants (2 µl) were 
then analysed by TLC. To test for BtCDH 
secretion, 10 µl of the B. thetaiotaomicron WT 
supernatant was analysed by western blotting 
using polyclonal anti-BtCDH antibodies. For 
this, filtered and unfiltered aliquots including a 
ten times concentrated aliquot of the former 
were analysed.  Whole cells (10 µl) prepared by 
resuspending centrifuged cells in 1 ml of PBS 
were also analysed alongside as controls. To 
confirm extracellular CS degradation during 
growth, cells were harvested at exponential 
phase (16 000 x g 1 min) and supernatant (8 µl) 
analysed by TLC. Supernatants were also 
analysed for secreted BtCDH activity. For this, 
supernatants were collected at exponential and 
centrifuged at 4000 x g for 5 min to remove 
cells. This was repeated once and the 
supernatants finally filtered through a 0.2 µm 
syringe cap filter (Pall Life Sciences). For each 
reaction, 20 µl of the supernatant was incubated 
overnight with 20 µl of 40 mg/ml CS substrate. 
The next day 4 µl of each sample was analysed 
by TLC.  
Mass spectrometry  
After purification of HA oligosaccharides, 200 
µl fractions were freeze dried and dissolved in 
distilled water. Samples were diluted 1:10 (v/v) 
with buffer B (80% acetonitrile / 20% 50 mM 
ammonium formate in water, pH 4.7) and 2.0 µL 
was injected onto an LC-MS instrument 
configuration comprising a NanoAcquity HPLC 
system (Waters) and QTof mass spectrometer 
(Impact II, Bruker). Analysis was performed via 
gradient elution from a ZIC-HILIC (SeQuant®, 
3.5 µm, 200Å, 150 X 0.3 mm, Merck) capillary 
column heated to 35oC and flowing at 5 µL/min. 
The elution gradient was as follows; 100% 
buffer B for 5 min, followed by a gradient to 0% 
B / 100% buffer A (50 mM ammonium formate 
in water, pH 4.7) over 40 min. 10 column 
volumes of buffer B equilibration was performed 
between injections. MS data was collected in 
positive ion mode, 50 – 2000 m/z, with capillary 
voltage and temperature settings of 2800 V and 
200 
o
C respectively, together with a drying gas 
flow of 6 L/min and nebulizer pressure of 0.4 
Bar.  The resulting MS data was analysed using 
Compass DataAnalysis software (Bruker). 
Phylogenetic analyses 
Sequences were retrieved from the NCBI 
database (cut–off ≥ 35% identity) from a BlastP 
search with BtCDH (residues 308-708) as query. 
After trimming the N and C-terminal DUFs, 
sequences were submitted to the Phylogeny.fr 
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server (37) in ‘‘one click mode’’ to generate a 
phylogenetic tree.  
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Figure 1. Modular architecture of native BtCDH and phylogenetic analyses. A) BtCDH 
(GenBank ID: AAO78434) contains an N-terminal lipoprotein signal peptide sequence (SP) and a 
large central region sandwiched by two domains of unknown function (DUF4988 and DUF4955). B) 
Phylogenetic tree showing the distribution of BtCDH homologues in selected species from various 
environments.  
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Figure 2. Analyses of chondroitin 4-sulfate (CSA) degradation by BtCDH lyase. A) Chemical 
structure of intact CSA.  B) TLC of CSA before and after digestion by BtCDH lyase. For the reaction, 
13.3 mg/ml of CSA from bovine trachea was treated with 0.3 µM of BtCDH lyase overnight. The 
reaction was stopped by boiling and 53.4 µg of digested CSA analysed by TLC. Lane 1; CSA, Lane 2; 
CSA treated with BtCDH lyase. C) HPAEC chromatogram of CSA digestion. Half the amount (26.7 
µg) of sample in A was analysed by HPAEC. D) 
1
H-NMR results of CSA digestion by BtCDH lyase. 
Digested CSA products were purified by SEC and later analysed by NMR. D1) NMR spectrum of 
undigested CSA. D2) Spectra of species from all SEC  fractions combined (fractions 1-43 in 
supplemental Figure 1). D3) Spectra of species from selected homogenous fractions (pooled fractions 
37-39 in  in supplemental Figure 1). Both spectra show resonance peaks for H1 and H4 (red and black 
star) at 5.1 and 5.9 ppm respectively, consistent with the formation of terminal unsaturated CSA 
oligosaccharides. D4) A typical chemical rearrangement of components of the non-reducing end sugar 
in CSA after lyase digestion. H4 and H1 are starred red and black respectively.  
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Figure 3. Evidence of BtCDH endo-lyase activity. A) TLC showing progressive degradation of 
hyaluronanic acid (HA
L
, 10-20 kDa) by BtCDH lyase over time. For the reaction, 32 mg/ml of HA
L 
was digested with 2 µM of enzyme. The reaction was stopped at various time points indicated and 64 
µg of each sample analysed by TLC. B) Mass spectrometry data of purified HA
L 
oligosaccharide 
species. B1: Spectrum for Δ
4,5
UA-disaccharide (Δ
4,5
UA-Di or [Band A]), B2: Spectrum for  Δ
4,5
UA-
octasaccharide (Δ
4,5
UA-Octa or [Band B]), B3: Spectrum for  Δ
4,5
UA-tetrasaccharide (Δ
4,5
UA-Tetra), 
B4: Spectrum for  Δ
4,5
UA-hexasaccharide (Δ
4,5
UA-Hexa) C) Structural representation of various 
species detected in B.  
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Figure 4. Activity of BtCDH against various chondroitin sulfate oligosaccharides. Substrates (1 
mg/ml each) were treated with 0.5 µM of BtCDH (shown as DPx +, with x being the number of 
constituent monosaccharides) overnight or diluted in equivalent volume of buffer as control (DPx). 
HPAEC chromatograms show major shifts in the signals of sulfated DP10 and DP12 oligosaccharides 
following treatment, accompanied by the appearance of a strong signals for the Δ
4,5
UA-GalNAc 
disaccharide in each case.  
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Figure 5. Effect of temperature and pH and metals  on BtCDH lyase activity.  A) Effect of 
temperature. Enzymatic activity was measured using 40 µM of CSA  as substrate in 20 mM NaH2PO4 
at pH 7.0 over different temperatures. B) Effect of pH.  BtCDH activity was measured at different 
pHs using 20 mM of various buffers at 37 
o
C.  C) Effect of various metals. Reactions were carried out 
in 20 mM NaH2PO4 buffer containing 5 mM EDTA, Mg
2+
, Ca
2+
, Mn
2+
, Co
2+
 and 1 mM  Zn
2+
 and Ni
2+
 
in separate experiments. 
 
 
Figure 6. Localization of BtCDH and evidence of extracellular chondroitin lyase activity. A) 
Western blots showing the detection of full and truncated versions of BtCDH (BtCDH
H 
 and BtCDH
L 
respectively) in B. thetaiotaomicron WT, ΔBtCDH and BtCDHFLAG cell extracts using polyclonal 
rabbit anti-BtCDH (top) and anti-FLAG Tag antibodies (bottom). B) Western blot analyses of 
proteinase K treated and control cells using anti-BtCDH antibodies. Top results show loss of BtCDH
H 
 
and BtCDH
L 
after the treatment of whole cells with proteinase K. Bottom results show detection of an 
intact periplasmic control protein, the BT4657 heparinase of B. thetaiotaomicron (16). C) 
Immunofluorescence detection of BtCDH in B. thetaiotaomicron WT and ΔBtCDH cells. Top pane 
shows green fluorescence signals of BtCDH. The middle pane shows blue signals from stained nuclei. 
Bottom pane is a merger of both signals. D) Evidence of extracellular CS degradation in B. 
thetaiotaomicron by TLC. Top gel; TLC analyses of CS degradation when whole cells of B. 
thetaiotaomicron WT, ΔBtCDH and BtCDHFLAG are incubated with CSA. Bottom gel; TLC 
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analyses of CS degradation when whole cells of B. thetaiotaomicron WT, ΔBtCDH and BtCDHFLAG 
are incubated with CSC 
 
 
Figure 7. Proposed model of chondroitin sulfate (CS) metabolism showing the context of BtCDH 
activity. BtCDH orchestrates extracellular degradation of sulfated CS (≥dp10) to generate 
oligosaccharide products which are imported through an outer membrane protein complex (encoded 
by BT_3331 and BT_3332 genes) into the periplasmic space. These are further degraded by 
periplasmic sulfatases, lyases and unsaturated glycoside hydrolase enzymes yielding end products 5-
keto, 4-deoxyuronate (kdu) and GalNAc which can be metabolised to provide energy for cell growth. 
Disaccharide intermediates generated during the process serve as signalling molecules activating 
expression of locus genes through binding to a hybrid two-component sensor protein (encoded by 
BT_3334) when CS is present. 
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Supplemental figure 1. Purification and TLC analyses  of end products of chondroitin 4-sulfate 
(CSA) digestion with BtCDH.  CSA was digested overnight and end-products separated by size 
exclusion chromatography followed by TLC analyses. Aliquots from fractions 1-43 and 37-39 were 
separately pooled and used for NMR experiments. 
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Supplemental figure 2. HPAEC analyses of HAL degradation by BtCDH. A) HPAEC 
chromatogram of time course samples. HAL (32 mg/ml) was incubated with 2 µM of BtCDH at 37 
o
C. 
Reactions were stopped at various time points indicated and 80 µg of digested HA analysed by 
HPAEC linked to a UV detector. B) Scatter plot showing the percentage of each product generated 
from the complete digestion of HA with BtCDH. Data was obtained by measuring the peak area for 
each product at the end of the reaction and expressing it as a percentage of the total. Δ
4,5
UA-Di:  
Δ
4,5
UA-disaccharide,  Δ
4,5
UA-Tetra: Δ
4,5
UA-tetrasaccharide, Δ
4,5
UA-Hexa: Δ
4,5
UA-hexasaccharide,  
Δ
4,5
UA-Octa: Δ
4,5
UA-octasaccharide  
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Supplemental figure 3. Time course degradation of chondroitin sulfate by BtCDH lyase. For 
each sample, 13.3 mg/ml of substrate was treated with 0.3 µM of BtCDH. The reaction was stopped at 
various time points indicated and 53.4 ug of digested substrate analysed by TLC. UAG: Δ
4,5
UA-
GalNAc disaccharide. Ctrl : Substrate without enzyme. 
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Supplemental figure 4.  Growth curves of B. thetaiotaomicron WT and ΔBtCDH strains on 
various GAG substrates. Cells were grown in minimal medium containing 1% final concentration of 
each GAG substrate as sole sources of carbon. Bt-wt; B. thetaiotaomicron WT, BtΔBtCDH; B. 
thetaiotaomicron ΔBtCDH mutant, CSA; chondroitin sulfate from bovine trachea, DS; dermatan 
sulfate from porcine intestinal mucosa, CSC; chondroitin sulfate from shark cartilage and HAL; 
Hyaluronanic acid sodium salt from Streptococcus equi 
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Supplemental figure 5: Analyses of culture supernatants of B. thetaiotaomicron WT, ΔBtCDH 
and BtCDHFLAG for secreted enzyme activity A) Analyses of supernatants by western blotting. 
Culture media at exponential phase growth in CSA were collected and centrifuged. The resulting 
supernatant (Sup1) was filtered to remove any remaining cells (Sup2) and later analysed by Western 
blotting using polyclonal rabbit anti-BtCDH antibodies.  Lysates from whole cells (WC) and Sup2 
samples concentrated ten times (10x Sup2) were also analysed.  B) Comparison of growth 
supernatants from cultures of B. thetaiotaomicron WT (Sup_WT), ΔBtCDH (Sup_ΔBtCDH) and 
BtCDHFLAG (Sup_BtCDHFLAG) in CSA (10 mg/ml). Each supernatant (8 ul) at exponential phase 
alongside a control CSA medium (ME) which was not inoculated with any cells was analysed by 
TLC.   C) Examination of growth supernatants for secreted enzyme activity. Supernatants (20 µl) 
obtained from cultures of B. thetaiotaomicron WT and ΔBtCDH in CSA were incubated overnight 
with 20 µl of 40 mg/ml CS substrate. The next day 4 µl of each sample was analysed by TLC.  
 
  
